EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP

Ilene Ceil Weitz iD, Howard Allen Liebman iD

British Journal of Haematology · 2023-10 · 203 (1) · 96-100

DOI: 10.1111/bjh.19070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 21.09.2023. Verfasst von Ilene Ceil Weitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jane Anne Nohl Division of Hematology, University of Southern California-Keck School of Medicine, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Thrombocytopenia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is a disorder characterized by low platelets due to increased clearance and decreased platelet production. While ITP has been characterized as an acquired disorder of the adaptive immune system, the resulting platelet autoantibodies provide ancillary links to the innate immune system via antibody interaction with the complement system. Most autoantibodies in patients with ITP are of the IgG1 subclass, which can be potent activators of the classical complement pathway. Antibody‐coated platelets can initiate complement activation via the classical pathway leading to both direct platelet destruction and enhanced clearance of C3b‐coated platelets by complement receptors. Similar autoantibody interactions with bone marrow megakaryocytes can also result in complement injury and ineffective thrombopoiesis. The development of novel therapeutic complement inhibitors has revived interest in the role of complement in autoantibody‐mediated disorders, such as ITP. A recent early‐phase clinical trial of a classical complement pathway inhibitor has demonstrated efficacy in a subset of ITP patients refractory to conventional immune modulation. In this review, we will analyse the role of complement in refractory ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaHumansComplement System ProteinsBlood PlateletsAutoantibodies

Stichwörter der Autor:innen

complementimmune thrombocytopenialow platelets

Substanzen

Complement System ProteinsAutoantibodies

Autor:innen und Institutionen

  • Jane Anne Nohl Division of Hematology, University of Southern California-Keck School of Medicine, Los Angeles, California, USA.

ORCID-Profile: Ilene Ceil Weitz, Howard Allen Liebman

Zitieren

APA

Weitz, I. C., & Liebman, H. A. (2023). Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP. British Journal of Haematology, 203(1), 96-100. https://doi.org/10.1111/bjh.19070

Vancouver

Weitz IC, Liebman HA. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP. British Journal of Haematology. 2023;203(1):96-100. doi:10.1111/bjh.19070

BibTeX
@article{Weitz2023,
  author = {Weitz, Ilene Ceil and Liebman, Howard Allen},
  title = {Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {203},
  number = {1},
  pages = {96--100},
  doi = {10.1111/bjh.19070}
}
Kostenlos starten →